Your symptoms made sense. We treat what they were managing.
If substances are part of what you’re carrying, we start with mental health and trauma. Healing begins in our Partial Hospitalization Program: a focused day of care, and home every night.
If opioid use is affecting your life or someone you love, call Women’s Recovery at 833.754.0554 for a private, conversation about possible next steps.
These are rooms at our Denver office. You spend the day here, and you go home at night.
Methadone and use treatment guidance begins with a useful distinction: opioid use disorder is a chronic, treatable condition involving opioid use, not a judgment about your character. You can explore broader treatment medication guidance or learn about buprenorphine treatment guidance.
They act on body systems involved in pain, breathing, and stress responses. Prescription status alone does not determine whether use has become harmful. If opioid use, cravings, or attempts to stop are disrupting health and daily responsibilities, an appropriate assessment can clarify what kind of care may fit, rather than leaving you to label the situation yourself.
Methadone, buprenorphine, and naltrexone can help people stop or reduce opioid use, while another medication may ease acute withdrawal symptoms. The right approach depends on an individual clinical evaluation. Learning what these medications can and cannot do may help you consider care without shame or pressure to make an immediate decision.
Methadone is an FDA-approved medication used to treat opioid use disorder. It can reduce opioid use and cravings without producing the strongly pleasurable effects associated with opioid drugs. Its place in care is different from information about outpatient treatment guidance or an Intensive Outpatient Program (IOP).
Evidence shows that it can help people reduce opioid use and remain engaged in treatment. That benefit does not mean methadone is automatically appropriate for every person. Medication decisions call for clinical care that considers your opioid use, health circumstances, current medicines, treatment goals, and ability to participate safely in ongoing care.
Treatment can offer enough stability for a person to address health, relationships, responsibilities, and recovery goals. Methadone can produce physical dependence, as many medications do, but that fact has a different meaning from compulsive, harmful use. A qualified treatment provider should guide medication decisions and any later changes.
Methadone treatment for opioid use disorder is provided through regulated treatment access, with clinical oversight rather than informal self-management. Women’s Recovery does not claim here to dispense methadone. You can read about Partial Hospitalization Program guidance and connect with Admissions at Women’s Recovery to discuss broader care needs.
Medication access follows its own requirements, while substance-use care can address the wider effects of opioid use. Understanding that distinction can prevent confusion about what a particular program provides and help keep medication decisions connected to appropriate clinical oversight and continuing treatment engagement.
Outpatient, more structured daytime care, and other treatment formats differ in intensity, but this information cannot determine an individual placement. A thoughtful assessment can consider safety, current opioid use, daily functioning, and existing treatment. For a conversation, contact Women’s Recovery at 833.754.0554 or visit 3801 E Florida Ave, Ste 650, Denver, CO 80210.
Evidence supports methadone, buprenorphine, and naltrexone as medications that can help you stop or reduce opioid use. Methadone and buprenorphine can also help you stay in treatment. Explore methadone and outpatient treatment guidance and buprenorphine guidance when considering your options.
Methadone may help some people remain in care longer. These are population-level findings, not promises. Your experience may be shaped by clinical needs, consistent access, other health concerns, personal preferences, and the support surrounding medication, so an individualized evaluation remains important.
That practical value matters because opioid use can affect health and everyday stability. Medication is not a moral shortcut, and needing it does not make recovery less meaningful. Appropriate care helps connect the evidence to your circumstances while respecting whether you are ready to consider medication, counseling, or another supported next step.
Physical dependence means the body has adapted to a medication and may react if it is stopped suddenly. Addiction involves harmful, compulsive use and is not established by dependence alone. For related context, see treatment medication and misuse guidance or methadone outpatient guidance.
This expected bodily adaptation can occur during prescribed treatment and does not, by itself, show that someone is addicted. Tolerance is also an adaptation in which the body responds differently after ongoing exposure. These concepts matter because calling all dependence addiction can increase shame and discourage people from considering medications that have documented benefits for opioid use disorder.
No general explanation can decide what is happening for you. Do not abruptly change methadone on your own, because sudden stopping can cause withdrawal. Medication changes belong with the treating clinician, while an assessment can address concerns about compulsive use, safety, and the broader support you may need.
Explore substance use care that sees the whole woman and women’s treatment programs for related guidance. Call admissions when you want to discuss your own situation.
Call AdmissionsMethadone is a medication used to treat opioid use disorder. Although it can cause physical dependence, supervised treatment is different from uncontrolled opioid use. Its documented purposes include reducing opioid use and supporting treatment retention. A clinician can assess whether this medication belongs in your individual care.
Yes. Methadone can reduce cravings without creating the strongly pleasurable effects associated with opioid drugs. It may also help people reduce opioid use and stay in treatment. Those benefits are supported across populations, but your likely response and treatment plan require an individual clinical evaluation.
Methadone and buprenorphine can be equally effective in helping people reduce opioid use, and both can support treatment retention. Methadone may help some people stay in care longer. That does not establish which medication is better for you, because an appropriate choice depends on individual clinical circumstances.
This information does not establish that Women’s Recovery dispenses methadone. Methadone for opioid use disorder is accessed through regulated treatment care. Women’s Recovery can have a conversation about broader recovery concerns and possible care needs at 833.754.0554, without promising medication access or a particular placement.
You can contact Women’s Recovery at 833.754.0554 or visit 3801 E Florida Ave, Ste 650, Denver, CO 80210. A conversation can help clarify how opioid use is affecting daily life and whether an assessment may be useful. Calling does not obligate you to enter treatment or choose methadone.
Read how we select health information sources and apply the Women’s Recovery editorial policy. These references provide general education and context; they do not establish an individual diagnosis, service, or treatment recommendation.
If you can't believe that yet, borrow my hope. Just long enough to find your own.
Women’s Recovery graduate
